Beyond fast track for drug approvals

N Engl J Med. 2004 Jul 29;351(5):501-5. doi: 10.1056/NEJMsb040064.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antineoplastic Agents / economics
  • Drug Approval / methods*
  • Drug Evaluation / legislation & jurisprudence*
  • Drug Industry / economics
  • Drug Industry / legislation & jurisprudence*
  • Humans
  • Marketing / legislation & jurisprudence
  • Neoplasms / drug therapy
  • Time Factors
  • United States
  • United States Food and Drug Administration

Substances

  • Antineoplastic Agents